Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 18;29(1):335.
doi: 10.1186/s40001-024-01932-2.

Inflammation accelerating intestinal fibrosis: from mechanism to clinic

Shuzi Xin #  1 , Xiaohui Liu #  1 , Chengwei He  1 , Han Gao  1   2 , Boya Wang  3 , Rongxuan Hua  4 , Lei Gao  5 , Hongwei Shang  6 , Fangling Sun  7 , Jingdong Xu  8
Affiliations
Review

Inflammation accelerating intestinal fibrosis: from mechanism to clinic

Shuzi Xin et al. Eur J Med Res. .

Abstract

Intestinal fibrosis is a prevalent complication of IBD that that can frequently be triggered by prolonged inflammation. Fibrosis in the gut can cause a number of issues, which continue as an ongoing challenge to healthcare systems worldwide. The primary causes of intestinal fibrosis are soluble molecules, G protein-coupled receptors, epithelial-to-mesenchymal or endothelial-to-mesenchymal transition, and the gut microbiota. Fresh perspectives coming from in vivo and in vitro experimental models demonstrate that fibrogenic pathways might be different, at least to some extent, independent of the ones that influence inflammation. Understanding the distinctive procedures of intestinal fibrogenesis should provide a realistic foundation for targeting and blocking specific fibrogenic pathways, estimating the risk of fibrotic consequences, detecting early fibrotic alterations, and eventually allowing therapy development. Here, we first summarize the inflammatory and non-inflammatory components of fibrosis, and then we elaborate on the underlying mechanism associated with multiple cytokines in fibrosis, providing the framework for future clinical practice. Following that, we discuss the relationship between modernization and disease, as well as the shortcomings of current studies. We outline fibrosis diagnosis and therapy, as well as our recommendations for the future treatment of intestinal fibrosis. We anticipate that the global review will provides a wealth of fresh knowledge and suggestions for future fibrosis clinical practice.

Keywords: Cytokine; ECM; Fibrosis; Inflammation; Intestinal microflora; Intestine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Pathophysiological alterations of cardiovascular and intestinal tract in humans during stress. The pressure signals sensed by the paraventricular nucleus of the hypothalamus go via the sympathetic nervous to thicken the endothelium and intima, increase collagen in the media, and thicken the left ventricle. The expression of occludin, connexin, and ZO-1 was found to be increased, as well as the of CD68+ and CD163+ Mφs in the intestine
Fig. 2
Fig. 2
Pathophysiological diagram of intestinal fibrosis. Inflammation is triggered by distinctive inflammatory and associated non-immune cells, as well as microbiota that enhance epithelial and endothelial EMT and EndoMT and catalyze myoblast activation through pathways such as cytokines, growth factors, and oxidative stress. This process ultimately results in the formation of fibrosis
Fig. 3
Fig. 3
Diagram illustrating putative IL-6 and TGF-β signaling processes involved in intestinal fibrogenesis and interaction with other signaling outlets. The processes behind the TGF-β and IL-6 signaling pathway in fibrosis depicted schematically
Fig. 4
Fig. 4
Diagram illustrating the of IL-36 cell signaling pathway in fibrosis process. IL-36 interacts to the IL-36R, which is heterodimerized with IL-1R3 (IL-1RAcP). The IL-36R/IL-36/IL-1R3 complex recruit MyD88 and interleukin-1 receptor-associated kinases (IRAKs), activating the mitogen-activated protein kinase(MAPK) and nuclear factor-κB (NF-κB) pathways. Dendritic cells and fibroblasts are activated and eventually fibrosis occurs. Direct induction shown as a solid black line, indirect induction as dotted black lines
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:340–350.e346. doi: 10.1053/j.gastro.2016.09.047. - DOI - PMC - PubMed
    1. Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev. 2021;302:211–227. doi: 10.1111/imr.12974. - DOI - PMC - PubMed
    1. Bamias G, Pizarro TT, Cominelli F. Immunological regulation of intestinal fibrosis in inflammatory bowel disease. Inflamm Bowel Dis. 2022;28:337–349. doi: 10.1093/ibd/izab251. - DOI - PMC - PubMed
    1. Tanni SE, Fabro AT, de Albuquerque A, Ferreira EVM, Verrastro CGY, Sawamura MVY, Ribeiro SM, Baldi BG. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev Respir Med. 2021;15:791–803. doi: 10.1080/17476348.2021.1916472. - DOI - PubMed
    1. Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight. 2021;6(13):e148980. doi: 10.1172/jci.insight.148980. - DOI - PMC - PubMed

LinkOut - more resources